about
Major Depressive Disorder Predicts Completion, Adherence, and Outcomes in Cardiac RehabilitationIndoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery diseaseInterleukin-17 in post-stroke neurodegenerationA meta-analysis of cytokines in Alzheimer's diseaseAssessing Music Perception in Young Children: Evidence for and Psychometric Features of the M-Factor.Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.Poststroke neuropsychiatric symptoms: relationships with IL-17 and oxidative stressRelationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery diseaseEffects of ω-3 fatty acids on cognitive performance: a meta-analysis.Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis.Kynurenine and depressive symptoms in a poststroke population.Potential roles of zinc in the pathophysiology and treatment of major depressive disorder.Zinc in depression: a meta-analysis.The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis.The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis.The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot studyCardiopulmonary fitness correlates with regional cerebral grey matter perfusion and density in men with coronary artery disease.Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery diseaseHigher cortisol predicts less improvement in verbal memory performance after cardiac rehabilitation in patients with coronary artery disease.Novel therapeutic targets in depression: minocycline as a candidate treatment.Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration.Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.Mapping inflammation onto mood: Inflammatory mediators of anhedonia.Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes.Role of Proinflammatory Cytokines in Dopaminergic System Disturbances, Implications for Anhedonic Features of MDD.Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis.Validity of the Center for Epidemiological Studies Depression scale in Type 2 diabetes.Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes.Peripheral inflammatory markers indicate microstructural damage within periventricular white matter hyperintensities in Alzheimer's disease: A preliminary report.Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: An exploratory study.Plasma Phosphatidylethanolamine and Triacylglycerol Fatty Acid Concentrations are Altered in Major Depressive Disorder Patients with Seasonal Pattern.Post-stroke Fatigue and Depressive Symptoms Are Differentially Related to Mobility and Cognitive Performance.Verbal memory performance and completion of cardiac rehabilitation in patients with coronary artery disease.Cardiopulmonary fitness is associated with cognitive performance in patients with coronary artery disease.Dementia: A link between microbial infection and cognition?Poor stimulus discriminability as a common neuropsychological deficit between ADHD and reading ability in young children: a moderated mediation model.Testing Measurement Invariance across Groups of Children with and without Attention-Deficit/ Hyperactivity Disorder: Applications for Word Recognition and Spelling Tasks.Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation.
P50
Q22305457-9BEC245A-2C7A-4B4B-BECA-3139506AED9EQ28249186-263A8680-1A76-4567-936C-E25DD504C390Q28284665-637D5FB5-AE2C-4404-B8B6-DDB9120E1B0FQ28289922-34F3FFB4-E04C-4DEE-BFC5-797E41D3D43AQ30398358-704C8319-AA92-430C-A856-056E828C37DEQ30713152-DC9D3E5E-4521-4913-BF06-617FFFB6E0A7Q33865660-BFD81575-57A1-4D0E-AD83-0A3805121FD6Q34122935-061B4DA3-0F29-4311-B1E5-942D4BE3DE46Q34150618-8EB9895D-785D-489A-94B6-34E2DC90622DQ34269777-60BAF502-6E11-422D-ACE3-3C8CBF24A289Q34274565-86FD9504-D725-45EC-8E53-8D37BEB843AEQ34337912-BB0B9FFD-02F6-4AED-A597-51E8ABE6DEF0Q34353975-B2554DF1-9C4E-47A7-8D74-B97C324AA7D9Q34540937-9079E4AC-9E32-4CD1-9C2D-FE27971194EEQ34556534-891D0CDF-D115-4DDD-8FFD-14677C9B4316Q34662653-377B0C0C-3F13-436E-9979-4389A7C42678Q35065194-6CE2DEB6-9DDE-4F54-9811-2B8697C2A720Q35118942-EF2FC408-AE6D-4D4C-BBAB-A53EC1F460EDQ35967384-E2F22561-F35C-419B-BF30-3D5FB4DD4FD3Q36582593-2D6909B4-0F81-4E3E-8423-EDC779C9317EQ38042194-DBBEC0C8-ECFE-49DA-8E09-DDA00DAFB52FQ38117027-C9502734-56CB-43DE-8CD0-1BB361C5721AQ38133067-938499E6-FF77-4DDD-BF93-C35330F2F231Q38189205-46C65EA6-3D66-4DF6-8098-E87B73B48868Q38750386-027B7C40-D81B-499A-9F96-1E07CC147F0BQ38810777-16CCC3CC-06E3-4240-B1C7-11CA75DE8442Q39081983-9F2C07F3-5032-4B37-A15A-FFBC62F9251DQ40507310-1AB28313-8B7B-4D12-91F3-A9CEA42FFC82Q40521396-4ED7E401-0377-49C6-B139-CC33415E6D2DQ41536779-E2E7958F-2775-4BCB-A080-78E4EB3AB2A7Q42173710-63C92F69-4E8D-47D6-B098-6D66E7F61F19Q43997406-8891B4E8-F37F-41A3-84DD-BE90F769904DQ46123962-2A7E5B35-7CAA-4F9F-A4AC-AEE4DE92EE4FQ46165537-9C45E17A-356E-4E01-A2AE-287A80031073Q46167356-69E3FEC8-A0A5-4C36-8DF3-5E6A3422187FQ46381464-D611D1FB-23EC-4402-B6CB-213DC66EB375Q46735176-42E2412C-9A42-47F5-9E56-A85BE8AD5013Q46868907-B51354B7-76BA-4D90-8BD2-3E4B96D478CDQ47111003-7A95C625-C3BA-431F-B361-250F89BBD144Q47379319-7FE5A472-00A1-4E2E-85C6-90623D45DF5A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Walter Swardfager
@ast
Walter Swardfager
@en
Walter Swardfager
@es
Walter Swardfager
@nl
Walter Swardfager
@sl
type
label
Walter Swardfager
@ast
Walter Swardfager
@en
Walter Swardfager
@es
Walter Swardfager
@nl
Walter Swardfager
@sl
prefLabel
Walter Swardfager
@ast
Walter Swardfager
@en
Walter Swardfager
@es
Walter Swardfager
@nl
Walter Swardfager
@sl
P106
P21
P31
P496
0000-0002-0030-8908